Renal cancer: From current evidence to future perspectives.
作者信息
Fiori Cristian, Porpiglia Francesco
机构信息
Department of Oncology-University of Turin, San Luigi Hospital, Orbassano, Turin, Italy.
出版信息
Asian J Urol. 2022 Jul;9(3):199-200. doi: 10.1016/j.ajur.2022.05.001. Epub 2022 May 30.
Abstract
摘要
相似文献
1
Renal cancer: From current evidence to future perspectives.肾癌：从当前证据到未来展望
Asian J Urol. 2022 Jul;9(3):199-200. doi: 10.1016/j.ajur.2022.05.001. Epub 2022 May 30.
2
Current management and future perspectives of metastatic renal cell carcinoma.转移性肾细胞癌的当前管理与未来展望
Int J Urol. 2014 Sep;21(9):847-55. doi: 10.1111/iju.12502. Epub 2014 May 27.
3
Current Status and Future Perspectives of Renal Denervation.肾去神经支配的现状与未来展望
Korean Circ J. 2021 Sep;51(9):717-732. doi: 10.4070/kcj.2021.0175. Epub 2021 Jun 8.
4
Current updates and future perspectives on the management of renal cell carcinoma.当前肾细胞癌治疗的最新进展和未来展望。
Life Sci. 2021 Jan 1;264:118632. doi: 10.1016/j.lfs.2020.118632. Epub 2020 Oct 25.
5
Biology of renal tumour cancer stem cells applied in medicine.应用于医学的肾肿瘤癌干细胞生物学
Contemp Oncol (Pozn). 2015;19(1A):A44-51. doi: 10.5114/wo.2014.47128.
6
Renal Nano-drug delivery for acute kidney Injury: Current status and future perspectives.肾脏纳米药物递送给急性肾损伤：现状与展望。
J Control Release. 2022 Mar;343:237-254. doi: 10.1016/j.jconrel.2022.01.033. Epub 2022 Jan 24.
7
Renal denervation in the management of resistant hypertension: current evidence and perspectives.肾去神经术在难治性高血压治疗中的应用：现有证据与展望。
Curr Opin Nephrol Hypertens. 2013 Sep;22(5):511-8. doi: 10.1097/MNH.0b013e3283640024.
8
[Ⅳ.Current Status of Treatment and Future Perspectives for Metastatic Renal Cell Carcinoma].[Ⅳ.转移性肾细胞癌的治疗现状与未来展望]
Gan To Kagaku Ryoho. 2021 Jan;48(1):46-51.
9
TNM staging system for renal-cell carcinoma: current status and future perspectives.肾细胞癌的TNM分期系统：现状与未来展望。
Lancet Oncol. 2007 Jun;8(6):554-8. doi: 10.1016/S1470-2045(07)70173-0.
10
Debulking surgery for malignant tumors: the current status, evidence and future perspectives.肿瘤减灭术治疗恶性肿瘤：现状、证据和未来展望。
Jpn J Clin Oncol. 2021 Aug 30;51(9):1349-1362. doi: 10.1093/jjco/hyab107.
引用本文的文献
1
Machine learning-assisted radiogenomic analysis for miR-15a expression prediction in renal cell carcinoma.机器学习辅助的放射基因组分析用于预测肾细胞癌中miR-15a的表达
BMC Cancer. 2025 Aug 20;25(1):1349. doi: 10.1186/s12885-025-13963-x.
2
Multiomics Analysis of Exportin Family Reveals XPO1 as a Novel Target for Clear Cell Renal Cell Carcinoma.输出蛋白家族的多组学分析揭示XPO1是透明细胞肾细胞癌的新靶点。
Int J Genomics. 2025 Jan 21;2025:3645641. doi: 10.1155/ijog/3645641. eCollection 2025.
本文引用的文献
1
Active Surveillance versus Immediate Intervention for Small Renal Masses: A Cost-Effectiveness and Clinical Decision Analysis.主动监测与即刻干预治疗小肾肿瘤：成本效益与临床决策分析。
J Urol. 2022 Oct;208(4):794-803. doi: 10.1097/JU.0000000000002812. Epub 2022 Jun 10.
2
External validation of the VENUSS prognostic model to predict recurrence after surgery in non-metastatic papillary renal cell carcinoma: A multi-institutional analysis.VENUSS 预后模型预测非转移性乳头状肾细胞癌手术后复发的外部验证：多机构分析。
Urol Oncol. 2022 May;40(5):198.e9-198.e17. doi: 10.1016/j.urolonc.2022.01.006. Epub 2022 Feb 13.
3
Clinical Review on the Management of Metastatic Renal Cell Carcinoma.转移性肾细胞癌管理的临床综述
JCO Oncol Pract. 2022 Mar;18(3):187-196. doi: 10.1200/OP.21.00419. Epub 2021 Sep 16.
4
Can preoperative renal mass biopsy change clinical practice and reduce surgical intervention for small renal masses?术前肾肿瘤活检能否改变临床实践并减少对小肾肿瘤的手术干预？
Urol Oncol. 2021 Oct;39(10):735.e17-735.e23. doi: 10.1016/j.urolonc.2021.05.024. Epub 2021 Aug 4.
5
Initial Observation of a Large Proportion of Patients Presenting with Clinical Stage T1 Renal Masses: Results from the MUSIC-KIDNEY Statewide Collaborative.对大量临床分期为T1期肾肿块患者的初步观察：来自全州范围内MUSIC-KIDNEY协作研究的结果
Eur Urol Open Sci. 2020 Dec 4;23:13-19. doi: 10.1016/j.euros.2020.11.002. eCollection 2021 Jan.
6
Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not.晚期肾细胞癌的治疗：免疫疗法已显示出总生存获益，而靶向疗法则未显示出此获益。
Eur Urol Open Sci. 2020 Nov 28;22:61-73. doi: 10.1016/j.euros.2020.11.003. eCollection 2020 Dec.
7
Predictive factors of recurrence after surgery in patients with non-metastatic renal cell carcinoma with venous tumor thrombus (UroCCR-56 Study).非转移性肾细胞癌伴静脉瘤栓患者术后复发的预测因素（UroCCR - 56研究）
World J Urol. 2023 Feb;41(2):295-302. doi: 10.1007/s00345-021-03640-6. Epub 2021 Mar 25.
8
Machine-Learning Models for Multicenter Prostate Cancer Treatment Plans.机器学习模型在前列腺癌多中心治疗计划中的应用。
J Comput Biol. 2021 Feb;28(2):166-184. doi: 10.1089/cmb.2020.0188. Epub 2020 Sep 25.
9
Prospects and Challenges of Artificial Intelligence and Computer Science for the Future of Urology.人工智能与计算机科学对泌尿外科未来的前景与挑战
World J Urol. 2020 Oct;38(10):2325-2327. doi: 10.1007/s00345-020-03428-0.
10
Three-dimensional Augmented Reality Robot-assisted Partial Nephrectomy in Case of Complex Tumours (PADUA ≥10): A New Intraoperative Tool Overcoming the Ultrasound Guidance.三维增强现实机器人辅助部分肾切除术治疗复杂肿瘤（PADUA≥10）：一种克服超声引导的新术中工具。
Eur Urol. 2020 Aug;78(2):229-238. doi: 10.1016/j.eururo.2019.11.024. Epub 2019 Dec 30.
Zotero 插件